Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological

Shan-Shan Zhang1,2, Lin Zhu1,2, Yan Peng1,2

  • 1Department of Histology and Embryology, Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, People's Republic of China.

Abstract

Insights

Running exercise enhances cognitive function in Alzheimer's disease (AD) mice by improving brain glucose metabolism and microglial activity. This highlights microglia as a key target for AD treatment through enhanced metabolism and plasticity.

Area of Science:

  • Neuroscience
  • Metabolic Research
  • Alzheimer's Disease Research

Background:

  • Alzheimer's disease (AD) pathogenesis involves microglia.
  • Triggering receptor expressed in myeloid cells 2 (TREM2) influences microglial metabolism and brain glucose utilization.
  • The impact of running exercise on microglial metabolism and brain glucose in AD models is not fully understood.

Purpose of the Study:

  • To investigate the effects of running exercise on brain glucose metabolism and microglial activity in APP/PS1 mice.
  • To explore the role of TREM2 in mediating the benefits of exercise in an AD mouse model.

Main Methods:

  • APP/PS1 and wild-type mice underwent 3 months of voluntary running or sedentary conditions.
  • Behavioral tests, [18F]FDG-PET, and hippocampal RNA-Seq were performed.
  • Microglial markers (GLUT5, TREM2, sTREM2, TYROBP, SPP1, p-SYK) and morphology were analyzed.

Main Results:

  • Running improved cognitive function and hippocampal glucose metabolism in APP/PS1 mice.
  • Exercise increased GLUT5, TREM2, SPP1, and p-SYK expression, while decreasing sTREM2.
  • Microglial number, process length, and GLUT5 expression increased; proliferation and CD68 activity were modulated.

Conclusions:

  • Running exercise preserves TREM2 levels and enhances brain and microglial glucose metabolism in AD mice.
  • Microglia are a potential therapeutic target for exercise-induced benefits in AD.
  • Modulating microglial metabolism and plasticity via TREM2 presents a novel AD treatment strategy.